|
| GLOBAL | RESECTABLE | BORDERLINE RESECTABLE | LOCALLY ADVANCED UNRESECTABLE |
| Number of patients (%) | 152 | 69 (45.4) | 32 (21.1) | 51 (33.5) |
| Age, years (range) | 69.0 (41 - 92) | 68.4 (41 - 92) | 69.6 (46 - 89) | 69.5 (52 - 88) |
| Female (%) | 44.7 | 46.4 | 46.9 | 41.2 |
| ECOG PS 2 - 4 (%) | 24.3 | 14.3 | 37.5 | 31.4 |
| Charlson Comorbidities ≥ 2 (%) | 23.7 | NA | NA | NA |
| DM (%) | 45.4 | 43.5 | 56.3 | 41.2 |
| Evolution time of DM (days, range) | 72.0 (0 - 360) | 78.0 (0 - 240) | 45.0 (2 - 180) | 60.0 (2 - 360) |
| Median number of medications (range) | 4.6 (0 - 16) | NA | NA | NA |
| Abdominal pain | 61.2 | 46.4 | 68.8 | 76.5 |
| Jaundice | 42.8 | 49.3 | 43.8 | 33.3 |
| Weight loss ≥ 10% | 31.6 | 16.0 | 28.1 | 37.3 |
| Evolution time of symptoms (days, range) | 21.0 (0 - 180) | 10.0 (0 - 180) | 25.5 (0 - 150) | 60.0 (0 - 180) |